Rx only · Injection, Solution · Intravenous

Vasopressin

5 ACTIVE SUPPLIERS — US

openFDA · updated weekly

US8 NDCs
5 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATC—

RxCUI (US)11149

US makers5 labelers

Packages8

DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

105

Rx · 2026 Q1

919

Units dispensed

-57%

Rx vs. year ago

Quarters · since 2025 Q1

Who makes it5 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
American Regent, Inc.	unknown	2	SUPPLYING
Fresenius Kabi USA, LLC	unknown	2	SUPPLYING
HF Acquisition Co LLC, DBA HealthFirst	unknown	2	SUPPLYING
Civica, Inc.	unknown	1	SUPPLYING
Sagent Pharmaceuticals	unknown	1	SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

May 13, 2024
RECALLRecall (Class II): Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only, For Intravenous …
Subpotent product in addition to having out-of-specification results for impurities. — Recalling firm: American Regent, Inc. — USA Nationwide